Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Neumora Therapeutics, Inc.”

6 pharma patents match "Neumora Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 6
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 6 pharmaceutical patents matching "Neumora Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

6 results for “Neumora Therapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 12371414

    Methods of treating neurological disorders

    Neumora Therapeutics, Inc. · Granted Jul 29, 2025 · Expires Jul 24, 2045

    granted
  2. US 12247037

    1-(2,6-diazaspiro[3.3]heptan-6-yl)-5,6-dihydro-4h-benzo[f][1,2,4]triazolo[4,3-A][1,4]diazepine derivatives and related compounds as vasopressin antagonists for the treatment of neuro-psychological disorders

    Neumora Therapeutics, Inc. · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  3. US 12171758

    Crystalline salt forms of kappa opioid receptor antagonist and products and methods related thereto

    Neumora Therapeutics, Inc. · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  4. US 12152038

    Vasopressin receptor antagonists and products and methods related thereto

    Neumora Therapeutics, Inc. · Granted Nov 26, 2024 · Expires Nov 21, 2044

    granted
  5. US 11993580

    Methods of treating neurological disorders

    Neumora Therapeutics, Inc. · Granted May 28, 2024 · Expires May 23, 2044

    granted
  6. US 11858943

    Vasopressin receptor antagonists and products and methods related thereto

    Neumora Therapeutics, Inc. · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted